Search for: "Eli, Inc." Results 401 - 420 of 1,001
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Aug 2013, 9:29 am by Derek T. Braslow
The generic and brand names of the drugs in this family include: • Exenatide (Byetta & Bydureon) marketed by Bristol Myers-Squibb and Amylin Pharmaceuticals, Inc. [read post]
28 Jul 2013, 9:29 am by Spencer Aronfeld
  Some of the other diabetes drugs being investigated include Bydureon and Onglyza, sold by Bristol-Myers Squibb; AstraZeneca and Victoza from Novo Nordisk; Tradjenta from Eli Lilly and Boehringer Ingelheim; and Nesina from Takeda. [read post]
3 Jul 2013, 12:27 pm by Kenan Farrell
Amylin Pharmaceuticals Inc. et al Court Case Number: 1:13-cv-01061-TWP-DMLFile Date: Tuesday, July 02, 2013Plaintiff: Consumer Health Information CorporationPlaintiff Counsel: James Dimos of Frost Brown Todd LLCDefendant: Amylin Pharmaceuticals Inc. [read post]
2 Jul 2013, 1:41 pm
The other day, I was blogging about tags, and somebody asked what are all the tags. [read post]
21 Jun 2013, 10:22 am
[If you want some handy tips on how to speed-read all those comments, try the Wired How-To Wiki, here] In case you missed it, Eli Lilly and Company v Human Genome Sciences, Inc UKSC 2012/0220 is not going on appeal to the United Kingdom's Supreme Court. [read post]
15 May 2013, 9:09 am by Lawrence B. Ebert
Eli Lilly & Co., 598 F.3d 1336, 1349 (Fed. [read post]
13 May 2013, 7:34 am
It’s going to be a busy week at the Supreme Court of Canada with nine appeals scheduled to be heard.May 13 — Federal Court — Eli Lilly Canada Inc. v. [read post]
6 Apr 2013, 6:11 pm by Larry Catá Backer
              In addition to myself, included in the discussion might be Ola Mestad, the Chair of the Norwegian Government Pension Fund Global, Eli Ane Lund, Executive head of the Secretariat of the Norway Government Pension Fund Global, Fabio Basan, Professor Roma III and founding director Sovereign Wealth Fund Centre; Edwin Truman, author of “Sovereign Wealth Funds: Threat or Salvation? [read post]
26 Mar 2013, 7:17 am by Brian A. Comer
The drug maker is challenging a Spartanburg County jury's 2011 decision that Janssen broke the law by writing to thousands of South Carolina doctors, downplaying the links between diabetes and its schizophrenia drug Risperdal, and by improperly claiming the drug was safer than competing medications, like Eli Lilly & Co.' [read post]
21 Mar 2013, 10:11 am by Lawrence B. Ebert
See In re Eli Lilly, 902 F.2d 943 (Fed. [read post]